How to buy InMode stock (INMD)

InMode is a medical devices business based in the US. InMode shares (INMD) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $17.19 – a decrease of 5.86% over the previous week. InMode employs 581 staff and has a trailing 12-month revenue of around $423.7 million.

Our top picks for where to buy InMode stock

Buy InMode stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

InMode stock price (NASDAQ: INMD)

Use our graph to track the performance of INMD stocks over time.

InMode shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$17.19
52-week range	$14.87 - $26.80
50-day moving average more info button	$18.11
200-day moving average more info button	$18.03
Wall St. target price	$21.33
PE ratio more info button	9.3716
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$1.83

Is it a good time to buy InMode stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

InMode price performance over time

Historical closes compared with the close of $17.15 from 2024-12-18

1 week (2024-12-13)	-6.08%
1 month (2024-11-21)	-7.22%
3 months (2024-09-20)	-1.55%
6 months (2024-06-20)	-3.71%

1 year (2023-12-20)	-21.37%
2 years (2022-12-20)	-51.31%
3 years (2021-12-20)	66.07
5 years (2019-12-20)	20.75

Is InMode stock undervalued or overvalued?

Valuing InMode stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of InMode's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

InMode's P/E ratio

InMode's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, InMode shares trade at around 9x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

InMode's PEG ratio

InMode's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.9004. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into InMode's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

InMode's EBITDA

InMode's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $136.5 million.

The EBITDA is a measure of a InMode's overall financial performance and is widely used to measure a its profitability.

InMode financials

Revenue TTM	$423.7 million
Operating margin TTM	37.06%
Gross profit TTM	$380.8 million
Return on assets TTM	10.5%
Return on equity TTM	21.05%
Profit margin	36.26%
Book value	$9.57
Market Capitalization more info button	$1.3 billion

TTM: trailing 12 months

InMode share dividends

We're not expecting InMode to pay a dividend over the next 12 months.

Have InMode's shares ever split?

InMode's shares were split on a 2:1 basis on 30 September 2021 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your InMode shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for InMode shares which in turn could have impacted InMode's share price.

InMode share price volatility

Over the last 12 months, InMode's shares have ranged in value from as little as $14.87 up to $26.8. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while InMode's is 2.15. This would suggest that InMode's shares are significantly more volatile than the average for this exchange and represent a higher risk.

InMode overview

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017.

Frequently asked questions

null
What percentage of InMode is owned by insiders or institutions?
Currently 10.757% of InMode shares are held by insiders and 64.149% by institutions. How many people work for InMode?
Latest data suggests 581 work at InMode. When does the fiscal year end for InMode?
InMode's fiscal year ends in December. Where is InMode based?
InMode's address is: Tavor Building, Yokne'am, Israel, 2069206 What is InMode's ISIN number?
InMode's international securities identification number is: IL0011595993 What is InMode's CUSIP number?
InMode's Committee on Uniform Securities Identification Procedures number is: M5425M103